Appeals Court Delivers Stunning $1.5 Billion Blow to Monsanto in Landmark Roundup Cancer Verdict

0
767
Bottles of Roundup weed and grass killer on display at a retail store. The popular glyphosate-based herbicide is at the center of high-stakes litigation after plaintiffs alleged it caused their cancer, leading to a $1.5 billion verdict against Monsanto.

Razor-Edge Insights

  • Record-Setting Verdict Upheld: Missouri appeals court stands firm on a $1.5 billion jury award against Monsanto, refusing to budge despite seven aggressive appeal points.
  • Glyphosate Litigation Tide Turns: Court rebuffs Monsanto’s reliance on EPA findings and affirms jury’s conclusion that Roundup’s glyphosate-based formula contributed to cancer in multiple plaintiffs.
  • Precedent for Punitive Damages: The ruling reinforces constitutional grounds for massive punitive awards when corporations fail to act on credible health warnings.

Monsanto’s Appeal Fails

KANSAS CITY – In a courtroom drama that gripped both the agricultural and legal worlds, the Missouri Court of Appeals for the Western District has affirmed a trial court’s staggering $1.5 billion judgment against Monsanto. The appellate decision, issued under case number WD87059, echoes far beyond the Show-Me State, sending shivers through the corridors of agrochemical companies and their legal teams nationwide.

The consolidated cases involved Daniel Anderson (California), Jimmy and Brenda Draeger (Missouri), and Valorie Gunther (New York)—all with deeply personal accounts of how years of using Monsanto’s flagship herbicide, Roundup, allegedly led to devastating diagnoses of non-Hodgkin’s lymphoma.